The Tanzania cardiovascular disease therapeutics market is expected to witness growth from $65 Mn in 2022 to $121 Mn in 2030 with a CAGR of 8.12% for the forecasted year 2022-2030. due to the increased prevalence of cardiovascular diseases as a result of lifestyle changes in Tanzania. Further, the government initiatives to promote cardiovascular health awareness in Tanzania have resulted in market expansion. The Tanzania cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Tanga Pharmaceuticals, Nashukuru Pharma, and Sanofi are the major players in the Tanzania cardiovascular disease therapeutics market.
The Tanzania cardiovascular disease therapeutics market is at around $65 Mn in 2022 and is projected to reach $121 Mn in 2030, exhibiting a CAGR of 8.12% during the forecast period. Tanzania's healthcare industry is expected to generate $15.26 Mn in revenue by 2023. A projected market volume of $22.24 Mn by 2027 is the outcome of revenue growing at a projected annual rate of 9.87% (CAGR 2023–2027). Tanzania has a weak healthcare infrastructure, limited resources, and high rates of maternal and infant mortality, HIV/AIDS, pneumonia, and malaria. The populace of Tanzania also has some of the lowest rates of worldwide access to medical professionals.
The most prevalent cardiovascular-related diseases in Tanzania were hypertensive heart disease (41%), valvular heart diseases (18%), coronary heart diseases (18%), peripartum cardiomyopathy (7%), non-hypertensive dilated cardiomyopathies (6%) in adults, and congenital heart disease (34%) in children. Adults aged 25 to 64 years are particularly impacted by cardiovascular diseases, which account for 13% of all NCD-related deaths in Tanzania. Tanzanian males died at a higher rate than women due to age-standardized CVD mortality rates. Blood clots are prevented from developing in the body by warfarin. If the body is producing blood clots or if there is a health issue that contributes to their formation. Vasodilators ease blood movement through your body by relaxing the blood vessels. If diet and statin therapy are not working, there is a novel class of cholesterol-lowering medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. They stop the activity of PCSK9, a liver enzyme. The liver's capacity to eliminate LDL (bad) cholesterol is hampered by that protein. An injured or weakened heart can pump more forcefully with the aid of inotropic treatment. It aids in making the cardiac muscle's contractions stronger when given intravenously. Additionally, it relaxes tightened blood arteries to improve blood flow. The rhythm of the heart may also quicken with inotropic treatment.
Market Growth Drivers
Tanzania is experiencing an increase in the prevalence of cardiovascular disease as a result of a number of variables, including sedentary lifestyles, unhealthy diets, and rising obesity rates. Consequently, there is an increasing need for efficient therapeutics to control and cure the disease. In order to tackle cardiovascular disease, the Tanzanian government has started a number of programs, including public awareness campaigns, initiatives to encourage healthy lifestyles, and enhancements to healthcare services. The demand for Tanzania's cardiovascular disease therapeutics market is anticipated to rise as a result of these efforts.
Market Restraints
In Tanzania, many people still do not have access to fundamental medical care, which includes cardiovascular disease diagnosis and therapy. This may reduce the desire for treatments for cardiovascular disease. Tanzania's healthcare infrastructure is still being developed and has very few resources and facilities. The distribution and administration of therapeutics for cardiovascular illness may become challenging as a result. Tanzania has little funding for cardiovascular disease therapeutic research and development, which can impede the creation of novel drugs and restrain the expansion of the Tanzania cardiovascular disease therapeutics market.
Key Players
The National Health Insurance Fund (NHIF) is Tanzania's primary source of health insurance protection. The diagnosis and treatment of cardiovascular disease are among the medical treatments that are covered by the NHIF. However, the particular plan and package that the person is enrolled in may affect the coverage for cardiovascular disease. The NHIF reimburses healthcare providers for services provided in accordance with a predetermined fee schedule on a fee-for-service basis. Additionally, the NHIF provides healthcare providers with capitation payments, which are set monthly sums paid for each enrolled person independent of the services received. In Tanzania, there are a number of private health insurance providers in addition to the NHIF that handle cardiovascular disease. These private insurance providers frequently provide more thorough coverage for cardiovascular illness and may cover more expensive treatments like heart surgeries. However, many Tanzanians still encounter financial obstacles to getting healthcare services, including treatment for cardiovascular disease, despite the availability of health insurance coverage. Healthcare out-of-pocket costs can be expensive, especially for those without health insurance coverage.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Disease Indication (Revenue, USD Billion):
By Drug Type (Revenue, USD Billion):
By Route of Administration (Revenue, USD Billion):
By Drug Classification (Revenue, USD Billion):
By Mode of Purchase (Revenue, USD Billion):
By End Users (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?